Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 12:04 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 217–240 of 331 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Observational data collection. Clear all

Conditions: Dementia
Interventions: Nutrition Status; Other
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Cranial Waveform in Normal Patients as a Result of Cardiac Cycle, Healthy
Interventions: Harmony Headset; Device
Lead sponsor: MindRhythm, Inc.; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Cupertino, California

Conditions: Pancreatitis
Interventions: Data Management and Monitoring; Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 2,345 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2030
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Acute Disease, Disease Progression, Critical Illness, Biomarkers, Aging, Digital Health, Wearable Electronic Devices, Remote Patient Monitoring
Interventions: Multimodal Digital Biomarker Monitoring; Other
Lead sponsor: Truway Health, Inc.; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 10,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2039
U.S. locations: 1
States / cities: New York, New York

Conditions: Intraventricular Hemorrhage, Premature Infants
Interventions: NIRS, aEEG, and CSF concentration of biomarkers; Procedure
Lead sponsor: University of Utah; Other
Eligibility: Up to 1 Year
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: No Applicable Condition; Study of Physiologic Monitor Alarms
Interventions: Observational with data collected; Other
Lead sponsor: Spectrum Ergonomics and Occupational Health Services; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Williamsport, Pennsylvania

Conditions: Spinal Cord Injury
Interventions: Overground Robotic Exoskeleton; Device
Lead sponsor: Ekso Bionics; Industry
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: San Rafael, California

Conditions: Molybdenum Cofactor Deficiency
Interventions: Not listed
Lead sponsor: Origin Biosciences; Industry
Eligibility: 1 Day and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 2
States / cities: Nashville, Tennessee • Milwaukee, Wisconsin

Conditions: Neonates
Interventions: Not listed
Lead sponsor: GE Healthcare; Industry
Eligibility: 23 Weeks to 6 Months
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: San Diego, California

Conditions: Chronic Heart Failure, CKD Stage 3
Interventions: AquaPass System; Device
Lead sponsor: AquaPass Medical Ltd.; Industry
Eligibility: 21 Years to 79 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 8
States / cities: La Jolla, California • San Francisco, California • Minneapolis, Minnesota + 5 more

Conditions: Head And Neck Cancer
Interventions: Questionnaires & Study Visit; Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 361 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Microvascular Disease, Retinal Disease
Interventions: XyCAM CRE Imaging; Device
Lead sponsor: Stuart Terry Eye Associates; Other
Eligibility: 21 Years to 100 Years
Enrollment: 350 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer, Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma, Melanoma (Skin Cancer), NSCLC (Non-small Cell Lung Cancer), Pancreatic (Exocrine Only), Mix of Solid Tumors (MOST)
Interventions: blood and tissue samples, blood and tissue samples; Diagnostic Test · Other
Lead sponsor: Paradigm Health; Industry
Eligibility: 18 Years and older
Enrollment: 1,350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2032
U.S. locations: 47
States / cities: Birmingham, Alabama • Bullhead City, Arizona • Casa Grande, Arizona + 43 more

Conditions: Stroke, Ischemic
Interventions: Viz LVO (De Novo Number DEN170073), Baseline Effectiveness Cohort; Device · Other
Lead sponsor: Viz.ai, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 3
States / cities: Atlanta, Georgia • Memphis, Tennessee • Harlingen, Texas

Conditions: Chronic Kidney Disease
Interventions: Not listed
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 130 Years
Enrollment: 1,052 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 11
States / cities: Riverside, California • San Francisco, California • Sanford, Florida + 8 more

Conditions: Breast Cancer
Interventions: Observational cohort; Behavioral
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 70 Years and older · Female only
Enrollment: 253 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2028
U.S. locations: 4
States / cities: Bangor, Maine • Boston, Massachusetts • Providence, Rhode Island

Conditions: Autism
Interventions: Eyelink Portable Duo, Integrated PCP Diagnosis and Eye-tracking Biomarker; Diagnostic Test
Lead sponsor: Indiana University; Other
Eligibility: 14 Months to 48 Months
Enrollment: 154 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 7
States / cities: Anderson, Indiana • Batesville, Indiana • Indianapolis, Indiana + 4 more

Conditions: Non-small Cell Lung Cancer Metastatic
Interventions: Predictive models (data collection); Other
Lead sponsor: Sophia Genetics SAS; Industry
Eligibility: 18 Years and older
Enrollment: 4,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 6
States / cities: Iowa City, Iowa • Worcester, Massachusetts • Rochester, Minnesota + 3 more

Conditions: Acute Myeloid Leukemia, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Esophageal Adenocarcinoma AJCC v8, Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, Esophageal Carcinoma, Fallopian Tube Carcinoma, Gastric Carcinoma, Hormone Receptor-Positive Breast Carcinoma, Invasive Breast Carcinoma, Lung Non-Small Cell Carcinoma, Lung Small Cell Carcinoma, Malignant Solid Neoplasm, Melanoma, Metastatic Prostate Carcinoma, Multiple Myeloma, Ovarian Carcinoma, Ovarian High Grade Serous Adenocarcinoma, Primary Peritoneal Carcinoma, Stage III Fallopian Tube Cancer AJCC v8, Stage III Lung Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8, Stage IV Colorectal Cancer AJCC v8, Stage IV Fallopian Tube Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8, Triple-Negative Breast Carcinoma
Interventions: Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Medical Chart Review, Paracentesis, Positron Emission Tomography; Procedure · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 13 Years and older
Enrollment: 1,600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 147
States / cities: Daphne, Alabama • Fairhope, Alabama • Mobile, Alabama + 115 more

Conditions: Papillary Microcarcinoma
Interventions: Not listed
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 750 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Preeclampsia (PE)
Interventions: Not listed
Lead sponsor: Sequenom, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 6,550 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 21
States / cities: Glendale, Arizona • Newark, Delaware • Miami, Florida + 15 more

Conditions: Pregnancy
Interventions: Data Collection; Other
Lead sponsor: Owlet Baby Care, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 173 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Lehi, Utah

Conditions: COVID, COVID19, SARS-CoV 2, Dyspnea
Interventions: Data Collection; Other
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 11,973 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Cancer
Interventions: Blood Sample, Surveys; Procedure · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 21 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 3
States / cities: Scottsdale, Arizona • Jacksonville, Florida • Rochester, Minnesota

Search by objective public record fields.

Assessment of DeMentia Nutrition Intervention Needs Among Care Recipients and carEgivers

500 "Normal" Adult Subjects Who Have Experienced no Known Brain Injury Will Participate in Collecting Data That Will Assist With the Optimization of the Diagnostic Capabilities of the Harmony in Detecting Neurologic Abnormalities.

Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies

Multimodal Digital Biomarker Prediction of Acute Clinical Deterioration

Intraventricular Hemorrhage and Post Hemorrhagic Ventricular Dilation: Natural Course, Treatment, and Outcome

Novel Self-charging, Medical-Grade Smart Insoles With AI/ML Edge Computing to Monitor Biometrics.

Health and Financial Impact on the Use of a Personal Exoskeleton in the Home and Community: a Case Study

A Retrospective, Observational, Noninterventional Data Collection Study for Patients With Molybdenum Cofactor Deficiency Who Have Been Previously Treated With Cyclic Pyranopterin Monophosphate (cPMP)

NICU-TECH RM9L-RS Probe ME Feasibility Study

Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System

Spousal Support in Head and Neck Cancer

Collecting Data on Retinal Blood Blood Flow and Blood Vessel Shape/Appearance Using an Investigational Device, XyCAM CRE, and to Then Compare Those Images With Images Collected From a Patient's Routine Clinical Examination.

Pan-tumor MRD Study

SYNCHRONISE: LVO Triage Timing and Outcome Study

A Study on Patients With Chronic Kidney Disease (CKD) to Assess Treatment Experience and Patterns, Effect of the Treatment, Patient Outcomes and Patient Quality of Life

Elevate! : An Elderly Breast Cancer Cohort Study

Validation of Indiana's Early Evaluation Hub System

Predictive Multimodal Signatures Associated With Response to Treatment and Prognosis of Patients With Stage IV Non-small Cell Lung Cancer

National Cancer Institute "Cancer Moonshot Biobank"

Genomic Predictors of Papillary Microcarcinoma Disease Progression

Non-Invasive Preeclampsia Screening and Biobank

Testing a Wearable Monitor for Fetal Heart Rate Estimation, Fetal Movement and Uterine Activity Detection

International SARS-CoV-2 (COVID-19) Infection Observational Study

Multi-Cancer Detection Observational Cohort Study